This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Janssen Biotech, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Xie Xu: Innovator in Psoriatic Arthritis Treatment
Introduction
Xie Xu is a notable inventor based in San Marcos, California. He has made significant contributions to the field of medicine, particularly in the treatment of psoriatic arthritis. His innovative approach has garnered attention in the medical community.
Latest Patents
Xie Xu holds a patent for a "Safe and effective method of treating psoriatic arthritis with anti-IL23 specific antibody." This method involves administering an IL-23 specific antibody, such as guselkumab, in a clinically proven safe and effective amount. The treatment aims for significant improvements in various clinical measures, including ACR20/50/70, PASI70/90/100, and others, assessed at multiple intervals after the initial treatment. He has 1 patent to his name.
Career Highlights
Xie Xu is currently associated with Janssen Biotech, Inc., where he continues to work on innovative treatments. His research focuses on improving patient outcomes in chronic conditions like psoriatic arthritis.
Collaborations
Xie Xu collaborates with Elizabeth C Hsia, contributing to advancements in their field. Their partnership exemplifies the importance of teamwork in medical research.
Conclusion
Xie Xu's work in developing effective treatments for psoriatic arthritis highlights his role as an innovator in the medical field. His contributions are paving the way for better patient care and outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile